3701 - 3750 of 6570 Results
Title
Year
-
OPENTitle: Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 2169End Page: 2180Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2013.169Best OA location URL: http://www.cell.com/article/S1525001616309431/pdfCitation Count: 61
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 43
-
OPENTitle: Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12104Citation Count: 5
-
OPENTitle: Incidental Lewy body disease: Clinical comparison to a control cohortJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 5Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22971Best OA location URL: http://doi.org/10.1002/mds.22971Citation Count: 141
-
OPENTitle: Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 1572End Page: 1579Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2008.146Best OA location URL: http://www.cell.com/article/S1525001616320548/pdfCitation Count: 117
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3140626Citation Count: 8
-
OPENTitle: Brain biochemistry in autopsied patients with essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 113End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3261329Citation Count: 54
-
OPENTitle: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1966End Page: 1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25647Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859844Citation Count: 143
-
OPENTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7041965Citation Count: 1110
-
OPENTitle: Caffeine consumption and risk of dyskinesia in CALM‐PDJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 380End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3608707Citation Count: 58
-
OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: http://doi.org/10.1002/mds.25637Citation Count: 9
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4050667Citation Count: 11
-
OPENTitle: Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implicationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 9Start Page: 1301End Page: 1304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25496Best OA location URL: http://doi.org/10.1002/mds.25496Citation Count: 38
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia2012OPENTitle: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 296End Page: 301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25213Best OA location URL: https://hdl.handle.net/2027.42/97160Citation Count: 96
-
OPENTitle: Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐MennonitesJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25818Best OA location URL: http://doi.org/10.1002/mds.25818Citation Count: 38
-
OPENTitle: Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBVJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 24Issue #: 3Start Page: 322End Page: 327Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0130-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6363916Citation Count: 73
-
OPENTitle: Results of the citalopram to enhance cognition in Huntington disease trialJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 3Start Page: 401End Page: 405Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25750Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3960314Citation Count: 65
-
OPENTitle: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 10Start Page: 978End Page: 988Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2Best OA location URL: http://doi.org/10.1016/S1474-4422(13)70210-2Citation Count: 269
-
OPENTitle: Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography studyJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25929Best OA location URL: http://doi.org/10.1002/mds.25929Citation Count: 122
-
OPENTitle: In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriersJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1197End Page: 1201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25893Best OA location URL: http://doi.org/10.1002/mds.25893Citation Count: 20
-
OPENTitle: Evaluation of mild cognitive impairment subtypes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 756End Page: 764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25875Best OA location URL: http://doi.org/10.1002/mds.25875Citation Count: 63
-
OPENTitle: ALS-FTD Complex Disorder due to <b><i>C9ORF72</i></b> Gene Mutation: Description of First Polish FamilyJournal Name: European NeurologyPublisher: S. Karger AGVol: 72Issue #: 1-2Start Page: 64End Page: 71Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000362267Best OA location URL: https://karger.com/ene/article-pdf/72/1-2/64/2724525/000362267.pdfCitation Count: 1
- Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease2010OPENTitle: Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 226Issue #: 1Start Page: 207End Page: 217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.09.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3108022Citation Count: 58
-
OPENTitle: Measuring mild cognitive impairment in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 5Start Page: 626End Page: 633Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25426Best OA location URL: http://doi.org/10.1002/mds.25426Citation Count: 145
-
OPENTitle: Mechanisms of VPS35-mediated neurodegeneration in Parkinson's diseaseJournal Name: International Review of Movement DisordersPublisher: ElsevierVol:Issue #:Start Page: 221End Page: 244Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/bs.irmvd.2021.08.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9053314Citation Count: 23
-
OPENTitle: β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control StudyJournal Name: Clinical EpidemiologyPublisher: Informa UK LimitedVol: Volume 15Issue #:Start Page: 695End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/clep.s405325Best OA location URL: https://www.dovepress.com/getfile.php?fileID=90360Citation Count: 8
-
OPENTitle: Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation AssayJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 2Start Page: 255End Page: 270Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-213085Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213085?id=journal-of-parkinsons-disease%2Fjpd213085Citation Count: 11
-
OPENTitle: The association between Mediterranean diet adherence and Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 6Start Page: 771End Page: 774Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24918Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3349773Citation Count: 226
-
OPENTitle: The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 4515End Page: 4515Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-40808-yBest OA location URL: https://www.nature.com/articles/s41598-019-40808-y.pdfCitation Count: 31
-
OPENTitle: Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau PathologyJournal Name: Clinical ChemistryPublisher: Oxford University Press (OUP)Vol: 69Issue #: 11Start Page: 1247End Page: 1259Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/clinchem/hvad139Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10895336/pdf/nihms-1962140.pdfCitation Count: 46
- VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease2009OPENTitle: VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 37Issue #: 2Start Page: 330End Page: 338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2009.10.011Citation Count: 77
-
OPENTitle: Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterationsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 145End Page: 156Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2012.12.001Best OA location URL: http://hdl.handle.net/11336/18335Citation Count: 67
-
OPENTitle: Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primatesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 25Start Page: eadu6050End Page: eadu6050Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adu6050Best OA location URL: https://doi.org/10.1126/sciadv.adu6050Citation Count: 5
-
OPENTitle: Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 79Issue #: 5Start Page: 873End Page: 886Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2013.06.046Best OA location URL: http://www.cell.com/article/S089662731300562X/pdfCitation Count: 374
-
OPENTitle: Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 56Issue #: 6-7Start Page: 944End Page: 955Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3820009Citation Count: 45
-
OPENTitle: Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 84Issue #: 4Start Page: 716End Page: 722Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2014.08.061Best OA location URL: http://www.cell.com/article/S0896627314008964/pdfCitation Count: 119
-
OPENTitle: Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 207Issue #: 1Start Page: 4End Page: 12Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2007.05.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2277100Citation Count: 239
-
OPENTitle: α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 71Issue #:Start Page: 191End Page: 203Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.03.038Best OA location URL: http://doi.org/10.1016/j.neuropharm.2013.03.038Citation Count: 43
-
OPENTitle: Investigating Convergent Actions of Genes Linked to Familial Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 5Issue #: 3-4Start Page: 182End Page: 185Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000113697Best OA location URL: https://www.karger.com/Article/Pdf/113697Citation Count: 42
-
OPENTitle: Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 2-3Start Page: 284End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.09.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3820002Citation Count: 22
-
OPENTitle: Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 56Issue #: 6-7Start Page: 956End Page: 969Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4106465Citation Count: 52
-
OPENTitle: M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaJournal Name: NeuronPublisher: Elsevier BVVol: 88Issue #: 4Start Page: 762End Page: 773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2015.10.039Best OA location URL: http://www.cell.com/article/S0896627315009332/pdfCitation Count: 249
-
OPENTitle: Impaired perception of biological motion in Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 30Issue #: 6Start Page: 720End Page: 730Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000276Best OA location URL: https://doi.org/10.1037/neu0000276Citation Count: 54
- Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways2016OPENTitle: Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain PathwaysJournal Name: NeuronPublisher: Elsevier BVVol: 90Issue #: 2Start Page: 333End Page: 347Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2016.03.028Best OA location URL: http://www.cell.com/article/S0896627316300198/pdfCitation Count: 207
- Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD2014OPENTitle: Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PDJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 4Start Page: 415End Page: 420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001184Best OA location URL: https://n.neurology.org/content/neurology/84/4/415.full.pdfCitation Count: 190
- Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice2010OPENTitle: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 41Issue #: 3Start Page: 706End Page: 716Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.12.008Citation Count: 187
-
OPENTitle: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2286End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092286Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823Citation Count: 22
-
OPENTitle: Basal activity of PINK1 and PRKN in cell models and rodent brainJournal Name: AutophagyPublisher: Informa UK LimitedVol: 20Issue #: 5Start Page: 1147End Page: 1158Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2023.2286414Best OA location URL: https://doi.org/10.1080/15548627.2023.2286414Citation Count: 32
-
OPENTitle: Putative PINK1/Parkin activators lower the threshold for mitophagy by sensitizing cells to mitochondrial stressJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 35Start Page: eady0240End Page: eady0240Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.ady0240Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.ady0240?download=trueCitation Count: 20
-
OPENTitle: Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in ratsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 6351End Page: 6351Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-85293-4Best OA location URL: https://www.nature.com/articles/s41598-021-85293-4.pdfCitation Count: 17